| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 117.51B | 115.59B | 108.28B | 103.61B | 93.74B | 81.37B |
| Gross Profit | 34.83B | 32.79B | 31.03B | 29.42B | 27.66B | 24.85B |
| EBITDA | 14.57B | 13.56B | 13.44B | 12.63B | 11.77B | 10.90B |
| Net Income | 4.41B | 1.50B | 6.18B | 5.72B | 1.21B | 3.94B |
Balance Sheet | ||||||
| Total Assets | 125.70B | 120.69B | 125.62B | 118.97B | 116.38B | 116.28B |
| Cash, Cash Equivalents and Short-Term Investments | 17.85B | 17.71B | 17.93B | 16.77B | 18.84B | 18.86B |
| Total Debt | 2.70B | 8.68B | 9.21B | 12.98B | 15.39B | 22.10B |
| Total Liabilities | 36.80B | 38.19B | 40.11B | 40.95B | 43.95B | 45.52B |
| Stockholders Equity | 88.64B | 82.13B | 85.16B | 77.66B | 72.13B | 70.49B |
Cash Flow | ||||||
| Free Cash Flow | 10.01B | 6.50B | 9.94B | 4.19B | 6.12B | 6.63B |
| Operating Cash Flow | 14.38B | 10.76B | 14.06B | 7.71B | 9.59B | 10.17B |
| Investing Cash Flow | -2.81B | -4.19B | -4.74B | -3.98B | -534.00M | -2.77B |
| Financing Cash Flow | -11.60B | -6.91B | -8.96B | -6.43B | -9.94B | -3.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥249.99B | 9.64 | 8.91% | 3.85% | 1.48% | 8.86% | |
78 Outperform | ¥113.25B | 15.71 | ― | 4.64% | 3.99% | -28.28% | |
77 Outperform | ¥88.98B | 8.96 | ― | 3.82% | 3.68% | -46.19% | |
76 Outperform | ¥181.59B | 11.03 | ― | 2.50% | -2.46% | -10.72% | |
76 Outperform | ¥117.68B | 0.96 | ― | 1.43% | -1.38% | 327.52% | |
67 Neutral | ¥85.85B | 17.07 | ― | 3.77% | -5.87% | 24.10% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |